Prophylactic Properties of Carrot Juice in Patients With High-Risk Colorectal Polyps

NCT06335420 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-11-20

No results posted yet for this study

Summary

The goal of this prospective randomized double-blinded bi-national study is to test the prophylactic effect of polyacetylenes from carrots on the population of patients who had a resection of high-risk adenomas of the large bowel.

The main question it aims to answer is: Will carrot juice rich in polyacetylenes inhibit neoplastic transformation and growth in high-risk humans?

Participants will have to drink 100 ml of juice daily after the adenoma resection for 1 year and keep a simple diary/calendar.

Researchers will compare the group with ingestion of Falcarinol (FaOH) / Falcarindiol (FaDOH) rich carrot juice versus the group consuming placebo juice, to see if the polyacetylenes significantly reduces neoplastic transformation and growth in high-risk patients.

Conditions

  • Colorectal Cancer Prevention

Interventions

DIETARY_SUPPLEMENT

Carrot juice from Yellowstone carrots cultivars

Consumption of 100 ml of carrot juice daily for 1 year

DIETARY_SUPPLEMENT

Placebo juice

Consumption of 100 ml of placebo juice daily for 1 year

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER
  • Umeå University

    collaborator OTHER
  • Uppsala University Hospital

    collaborator OTHER
  • Svendborg Hospital

    collaborator OTHER
  • Ersta Hospital, Sweden

    collaborator OTHER
  • St Goran's Hospital

    collaborator OTHER
  • Sahlgrenska University Hospital

    collaborator OTHER
  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Baatrup, Professor · OUH og Svendborg Sygehus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-20
Primary Completion
2027-06-01
Completion
2027-12-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06335420 on ClinicalTrials.gov